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  A b s t r a c t
   Background:  Subjects with ischemic lesions have an increased risk of dementia. In addition, 
Alzheimer’s disease (AD) and vascular cognitive impairment share many risk factors. These ob-
servations suggest that different diseases that cause altered blood perfusion of the brain or 
hypoxia promote AD neurodegeneration. In this case-control, cross-sectional study, we sought 
to test the hypothesis that hypoxia facilitates cognitive decline.    Methods:  We looked for altered 
neuropsychological performance in subjects with chronic obstructive pulmonary disease 
(COPD) without apparent cardio- or cerebrovascular diseases or risk factors for atherosclerosis. 
A selected, homogeneous group of workers from two ceramic factories in a small town of cen-
tral Italy was enrolled in this study.   Results:  The COPD patients had a slightly, but significantly 
worse performance than controls in a number of neuropsychological tests.   Conclusion:  The 
findings are consistent with the working hypothesis that chronic hypoxia facilitates cognitive 
decline.     Copyright © 2011 S. Karger AG, Basel
  Published online: November 16, 2011
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  Introduction
    In the brain of subjects with cognitive impairment, ischemic lesions often coexist with 
senile plaques and neurofibrillary tangles, the hallmarks of Alzheimer’s disease (AD). The 
number or extent of the ischemic lesions strongly increases the odds of clinical dementia in 
persons with high levels of AD pathology   [1, 2]  . In addition to being relevant to the clinical 
expression of the cognitive dysfunction, the infarcts may also reveal pathogenic aspects that 
are potentially common to AD and vascular cognitive impairment. A number of findings do 
in fact suggest that atherosclerosis or endothelial dysfunction of the brain vessels promotes 
the neurodegeneration associated with AD   [3]  . The hypothesis has received wide attention 
in the last years, mostly because of studies indicating that AD and vascular cognitive impair-
ment share many risk factors   [4]  . Although the mechanisms by which a deregulated micro-
circulation would trigger AD are largely unknown   [5]  , chronic hypoperfusion seems to play 
a crucial role. For instance, epidemiological data suggest a link between low blood pressure 
in older adults and cognitive decline   [6]  . Furthermore, hemodynamic microcirculatory in-
sufficiency and hypometabolism (as demonstrated in mild cognitive impairment) seem to 
appear years before the onset of AD, suggesting that the phenomena do not simply reflect 
the altered brain function   [7, 8]  . Rats with permanent occlusion of both carotid arteries, a 
condition associated with low perfusion  [9]  and no acute histological damage, develop learn-
ing impairment and amyloid deposits   [10]  . The findings altogether suggest that different 
diseases that cause altered blood perfusion of the brain promote AD neurodegeneration. 
Thus, it is a consistent hypothesis that hypoperfusion plays a pathogenic role in AD neuro-
degeneration. A number of mechanisms have been proposed to be involved in mediating the 
effect of hypoperfusion. For instance, hypoperfusion can lead to overexpression of cyclin-
dependent kinase 5 (CDK5), a serine-threonine kinase that is critical to synapse formation 
and synaptic plasticity   [11–13]  .
    The role of hypoxia in the hypothesized hypoperfusion-mediated neurodegeneration is 
also questioned. Chronic hypoxia, for instance, might mimic chronic hypoperfusion, imply-
ing that the deleterious effect of hypoperfusion is entirely mediated by the hypoperfusion-
induced hypoxia. As an alternative, hypoperfusion might carry some additional pathogenic 
relevance, possibly because of hypoxia-independent mechanisms associated with dysfunction 
of the neurovascular unit. Of course, the issue has no easy answer, if not for the difficulty of 
defining ‘chronic hypoxia’ and ‘chronic hypoperfusion’. There are, however, a few, inconclu-
sive data favoring a role of chronic hypoxia per se. For instance, a longitudinal study showed 
that anemia, or low hemoglobin levels, in subjects with good baseline cognitive performance 
doubles the risk of developing dementia with respect to persons without anemia   [14]  . It is hy-
pothesized, therefore, that chronic hypoxia     promotes AD neurodegeneration, probably by 
causing mitochondrial dysfunction and activation of programmed cell death   [15]  .
    In order to address this issue, we assessed neuropsychological function in patients with 
chronic obstructive pulmonary disease (COPD) without apparent cardio- or cerebrovascular 
diseases, or risk factors for atherosclerosis in a small case-control study. For this purpose, we 
selected a group of workers from a ceramic factory in a small town of central Italy. The work-
ers are at risk for COPD because of the exposure to silica dust.
  M e t h o d s
  S u b j e c t s
    The study was carried out in subjects selected from a cohort of 955 workers from two 
ceramic factories in the province of Viterbo in central Italy. In a prevention program spon-404
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sored by the government health system aiming to determine the risk of COPD associated 
with exposure to silica dust, the factory workers have been followed since 1994 by the Occu-
pational Health Unit of Viterbo. The program includes periodic spirometric tests and acqui-
sition of data for quantifying exposure to silica dust, expressed in terms of the cumulative 
exposure index as described previously   [16]  .
  A total of 89 subjects were found to meet the following inclusion criteria: age 35–65 years 
and diagnosis of COPD confirmed by a Tiffeneau index at the spirometric test  !  70%  [17] . An 
invitation letter to join the project resulted in 38 positive answers. The 38 eligible workers 
underwent an individual interview to assess the presence/absence of the following exclusion 
criteria: cognitive impairment (MMSE   !  26) and/or diagnosis of dementia, psychiatric dis-
turbance, hypertension, alcoholism (  1  40 g of alcohol per day), diabetes, pharmacological 
treatment affecting cognitive function, systemic disease or cerebral lesions potentially affect-
ing cognitive performance, severe visual or auditory impairment, low education ( !  3 years of 
formal school), or uncooperative behavior. Following the interview, a total of 16 cases were 
excluded, because of hypertension (8), diabetes mellitus (1), cardiac diseases, e.g. myocardial 
infarction or atrial fibrillation (4), liver (1) or thyroid disease (1), or depression (1). Of the 89 
subjects, 22 cases were, therefore, included.
  Controls were recruited from the remaining group of co-workers without COPD. Name-
ly, individuals were randomly selected from the list of co-workers and included as controls, 
or rejected, on the basis of matching (age and gender) with one of the cases. The procedure 
was carried out until all the 22 cases had their own matching control. All the 44 subjects, 22 
cases and 22 age- and sex-matched controls, underwent further spirometry assessment and 
completed a standard CECA (European Commission for Steel and Coal) questionnaire for 
chronic bronchitis and pulmonary emphysema   [18]   before study entry. All the 44 subjects 
included completed the study.
  Neuropsychological  Assessment
  Cognitive performance was evaluated using a battery of neuropsychological tests gener-
ally employed in the clinical setting. The tests were selected to provide information about 
different areas of cognition: selective attention (visual search-attentional matrices; trail mak-
ing test, part A)   [19]  , cognitive flexibility/divided attention (trail making test, part B)   [20]  , 
verbal long-term memory (story recall test)   [21]  , verbal and spatial short-term memory (dig-
it span/Corsi test)   [21]  , non-verbal logical reasoning and problem-solving ability (Raven’s 
colored progressive matrices)  [22] , word generation by phonological and semantic cues [pho-
nological and semantic (animals) verbal fluency test]   [21]  , auditory comprehension of com-
plex sentences (token test)  [20] , spatial abilities and constructional praxis (copying drawings) 
  [19]  . The neuropsychological test battery was performed by a neuropsychologist who was 
blinded to the data on pulmonary function.
  Statistical  Analysis
  Statistical analyses were performed by means of the t test for unpaired data and Pearson’s 
correlation. p  !   0.05 was considered statistically significant. All analyses were performed us-
ing the Statistical Package for the Social Sciences (SPSS, version 13.0).
  R e s u l t s
    Demographic and occupational variables of the subjects are shown in   table 1  . All the 
subjects were male, and had similar age and educational level. There was no difference be-
tween the two groups in the length of continuous service in the factory as well as in the cu-405
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mulative exposure index to silica dust. Smoking habits, expressed as number of packets of 
cigarettes per year, was slightly different (p = 0.053) between COPD and control groups. The 
mean ( 8  SD) duration of COPD was 5  8   2 years (range 2–7). The Tiffeneau indices of all the 
subjects are reported in   table 2  .
    The MMSE score was significantly different between COPD subjects and controls 
(mean  8   SD, 29  8   1 and 30  8   1, respectively, p = 0.004). Furthermore, patients with COPD 
had lower scores than controls in a number of different tests, including Raven’s colored pro-
gressive matrices (p = 0.001), trail making parts A and B (p = 0.010 and p = 0.001, respec-
tively), visual search (p = 0.019), story recall (p = 0.023), and phonological and semantic flu-
ency (p = 0.001 and p = 0.003, respectively;   table 3  ;   fig. 1  ). Pearson’s correlation analysis 
showed a correlation between the Tiffeneau index and MMSE (p = 0.019).
  Table  1.  D  emographic and occupational data on the study groups
 COPD  group
  (n  =  22) 
 Control  group 
  (n  =  22) 
 p
  value 
 Age,  years  50  8  7 47  8  5   NS 
  Length of service, years  26  8  8 25  8  8   NS 
  Cumulative exposure indices to silica dust   12  8  19 11  8  18   NS 
  Education, school years  8  8  2 9  8  3   NS 
  Smoking status, packs/year   547 8  449   315  8  210   NS 
  N  S = Nonsignificant (p > 0.05). Four subjects in the control and none in the COPD group were never 
smokers. 
 
 
 Groups   Mean   SD   Range 
 COPD     61   9   39–70 
 Control   79   5   70–88 
 
 
  Table  2.  T  iffeneau index values 
in patients with COPD and 
controls
 
  Fi g .   1.   Differences in neuropsy-
chological evaluation between 
COPD patients and controls. 
Each bar represents the mean   8   
SD percent difference compared 
to the controls. Raven = Raven’s 
colored progressive matrices; 
TMA/TMB = trail making test 
part A/part B; VS = visual search; 
SR = story recall; Corsi = Corsi 
test; Digit = digit span test; To-
ken = token test; PF = phonolog-
ical fluency; SF = semantic flu-
ency; CD = copying drawings. 
  *    p   ^   0.05;   **   p   ^   0.01. 406
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  Discussion
    The results of this study show that people with COPD had a slightly, but significantly 
worse performance than controls in a number of neuropsychological tests. The two groups 
specifically differed in tests that refer to executive function, attention, non-verbal logical rea-
soning and problem-solving ability, verbal long-term memory and language. The data sug-
gest an involvement of both subcortical and cortical functions. 
  We hypothesize that the altered performance in the COPD group is attributable to brain 
dysfunction associated with chronic hypoxia. The occurrence of hypoxia in COPD can be 
inferred on the basis of a number of studies   [23]  . Because of ethical concerns regarding the 
invasiveness of the procedure, in fact, we did not perform any measurement of partial pres-
sure of oxygen in arterial blood in our participants. 
    A few, mostly anecdotal, reports have previously indicated the likelihood of an associa-
tion between COPD and cognitive impairment   [24]  , with impairment being diffuse   [25, 26]   
or confined to immediate  [27]  or verbal memory  [28] . Our findings of an involvement of both 
subcortical and cortical functions are at odds with previous data obtained in an inhomoge-
neous group of subjects hospitalized for COPD   [24]  .
    A potential confounding variable in the interpretation of our data concerns cigarette 
smoking. There was, in fact, a slight difference between the two groups in the number of 
cigarettes smoked per year (p = 0.053). Smoke may have a role in the pathogenesis of COPD. 
Smoke is a controversial risk factor for cognitive impairment in midlife   [19, 29]   and is also 
an independent risk factor for cerebrovascular diseases   [30]  . Therefore, we cannot rule out 
an underlying, asymptomatic, ischemic brain pathology that would account for the cognitive 
difference between the two groups. The hypothesis, however, seems unlikely in view of the 
relatively young age of the subjects and the careful exclusion of vascular risk factors in the 
selection of the subjects. Furthermore, correlation analyses showed no association between 
smoking status (expressed in packs/year) and neuropsychological performance (data not 
shown). 
    The subjects were included following a progressive refusal/exclusion procedure. Such a 
recruitment method, together with the small sample size, represents a limitation of the study 
  Table  3.  N  europsychological tests performed in the study groups
 Tests   COPD  group
  (n  =  22) 
 Control  group
  (n  =  22) 
 p
  value 
  Raven’s colored progressive matrices  28  8  5   32 8  3   0.001 
  Trail making A  43  8  12   34 8  8   0.010 
  Trail making B   116 8  52   72  8  25   0.001 
 Visual  search  66  8  7   71 8  7   0.019 
 Story  recall  14  8  3   16 8  3   0.023 
 Corsi  4  8  1 5  8  1   NS 
 Digit  span  5  8  1 5  8  1   NS 
 Token  33  8  2   33 8  1   NS 
 Phonological  fluency  24  8  7   32 8  8   0.001 
 Semantic  fluency  16  8  4   20 8  4   0.003 
 Copying  drawings  12  8  1   13 8  1   NS 
 M eans   8   SD of the scores reported at each test in the COPD and control groups. NS = Nonsignificant 
(p > 0.05). 
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that might raise the doubt of a sample bias. However, the findings gain strength from the 
distinctive homogeneity of the population examined in this report. It is worth stressing that 
both COPD and control subjects have been living in the very same small town and have been 
working in the same factory for   1  20 years. In addition, all the individuals enrolled have a 
similar education/social background. All of them have had periodic assessments of respira-
tory function for   1  5 years, and the medical records allowed us to exclude cerebrovascular 
diseases or other potentially confounding factors.
    In conclusion, the results of this study are consistent with the working hypothesis that 
chronic hypoxia facilitates cognitive decline.
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